Editorial board

EDITOR IN CHIEF

Michael Morse: Duke University Medical Centre, USA

EDITORIAL BOARD

Ivo Abraham: The University of Arizona, USA

Mauro Alaibac: University of Padua, Italy

Anthony Atala: Wake Forest Institute for Regenerative Medicine, USA

Fabiola Atzeni: University of Messina, Italy

Constantin Baxevanis: Saint Savas Cancer Hospital, Greece

Alessandro Busca: San Giovanni Battista Hospital, Italy

Laurent Peyrin-Biroulet: University Hospital of Nancy, France

Cesar Borlongon: University of South Florida, USA

George Calin: Anderson Cancer Center, USA

Michele Caraglia: Seconda Universita degli Studi di Napoli, Italy

Maria Castro: The University of Michigan School of Medicine, USA

William Cho: Queen Elizabeth Hospital, Hong Kong

Myron S Czuczman: Roswell Park Cancer Institute, USA

Angus Dalgleish: St George's Hospital Medical School, UK

Silvo Danese: Humanitas Research Hospital, Italy

Constantin A Dasanu: University of California, USA

Dwaine Emerich: InCytu Inc., USA

Steven Feldman: Wake Forest School of Medicine, USA

Arthur E Frankel: Scott & White Cancer Research Institute, USA

Allan Goldstein: The George Washington University School of Medicine, USA

Andrzej Górski: Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Poland

Peter J Hudson: Avipep Pty Ltd., Australia

David Kirn: Imperial College School of Medicine, UK

Herwig Kollaritsch: Medical University of Vienna, Italy

Robert Kreitman: National Cancer Institute, USA

E Michael Lewiecki: University of New Mexico, USA

M Alan Menter: Baylor University Medical Center, USA

Alireza Minagar: Louisiana State University Health Sciences Center, USA

Chi-Chiu Mok: University of Hong Kong, Hong Kong

Gorka Orive: University of the Basque Country, Spain

Ian Pringle: Trinity College, Oxford University, UK

Nikolai Rainov: Martin Luther University Halle-Wittenberg, Germany

Dario Sangiolo: IRCC - Institute for Cancer Research and Treatment, Italy

Daniele Santini: University Campus Bio-Medico, Italy

Susan Slovin: Memorial Sloan Kettering Cancer Center, USA

Michael Vajdy: EpitoGenesis, Inc., USA

Giovanni Vitale: University of Milan, Italy

Daniel Wendling: CHRU de Besancon, France

Heinz Wiendl: Universtiy of Munster, Germany